Navigation Links
Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting

SAN DIEGO--(BUSINESS WIRE)--Jun 6, 2007 - Inovio Biomedical Corporation (AMEX:INO), focused on the development of DNA vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced today the company delivered multiple presentations on preclinical study results and new device innovations relating to its electroporation-mediated DNA delivery technology at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT). Inovio's DNA delivery systems are designed to enhance the potency of DNA-based immunotherapies and vaccines against infectious diseases and cancers.

Three presentations reported preclinical data regarding immune responses to DNA vaccines directed against major infectious diseases including malaria, HIV, and hepatitis C, respectively. In all cases, Inovio's electroporation technology was well tolerated and significantly enhanced both humoral (antibody) and cellular (T-cell) immune responses when compared with traditional vaccine delivery methods.

A study conducted in collaboration with the Naval Medical Research Center showed that electroporation-augmented immunization with a DNA vaccine against a malaria parasite-specific antigen not only enhanced humoral and cellular immune responses, but more importantly caused a significant reduction of parasite burden compared to non-immunized control animals.

A study conducted in partnership with Wyeth tested a multi-antigenic DNA vaccine against HIV. Using only one-fifth the dose used without electroporation, antibody responses were increased several hundred-fold by electroporation. The cellular immune response was enhanced 10 to 40-fold, translating into a 50 to 200-fold increase (8 weeks and 22 weeks, respectively) in vaccine potency.

A third study conducted in partnership with the Karolinska Institute, Sweden, supported the safety of electroporation in detailed experiments a
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
2. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
3. Inovio: DNA delivery technology shows positive human results
4. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
5. Inovio Biomedicals DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
8. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
9. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
10. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
11. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Post Your Comments:
(Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
(Date:7/10/2014)... Yesterday, former Congressman Patrick Kennedy ... facility. Rep. Kennedy and Dick Moberg ... research in neurological disease and treatment. ... Garen Staglin , created One Mind, a ... that will radically accelerate the development and implementation ...
(Date:7/10/2014)... 2014   LabStyle Innovations Corp . (OTCQB:DRIO), developer ... the appointment of Professor Richard B. Stone ... of Directors. Prof. Stone brings over ... LabStyle as an entrepreneur, venture capitalist public, company ... expert. He currently serves on the board of ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... Heska Corporation (Nasdaq: HSKA ) announces the following Webcast: ... Quarter 2011 Earnings Conference Call on the Web When: Monday, ... (click on the Q3 2011 Earnings Call link on the front ... Simply log on to the web at the address above.   ...
... premium provider of new and refurbished ultrasound solutions, today announced ... GE E8/E9 transducers.  MedPro is the first and only provider ... ultrasound systems and has been offering this repair in partnership ... six months. In addition to the new E8/E9 ...
Cached Medicine Technology:Webcast Alert: Heska Announces Third Quarter 2011 Earnings Conference Call Webcast 2MedPro Imaging to Repair GE E8/E9 Ultrasound Transducers 2
(Date:7/13/2014)... 2014 Recently, iFitDress.com, one of the ... its beautiful collection of brown evening dresses ... now available at discounted prices, up to 50% off. ... high quality; they are carefully made according to most ... gowns, iFitDress.com also offers pretty accessories: wedding shoes, dancing ...
(Date:7/13/2014)... to get the best treatment and variations in the ... survival for blood cancer patients still varies widely between ... of survival in European adults to date, published in ... is that 5-year survival for most cancers of the ... likely reflecting the approval of new targeted drugs in ...
(Date:7/13/2014)... Nature Genetics identifies a novel genetic and ... esophagitis (EoE), opening up potential new therapeutic strategies ... , EoE is a chronic inflammatory disorder of ... hypersensitivity to certain foods and an over-accumulation in ... (part of the body,s immune system). EoE can ...
(Date:7/13/2014)... 2014 Victorian Hotel has recently announced ... rental of bikes for its "Cycle the City" program, ... to tour the area using a rental bicycle, available ... love to call Vancouver home, as it is a ... and picturesque journeys through the countryside. Vancouver hotel rooms ...
(Date:7/13/2014)... 13, 2014 Advanced boilers are ... least amount of fossil fuels, produce high-capacity power, ... to increased global warming and climate change concerns, ... reduce harmful gas emissions and pollutants coming from ... in the global advance boilers market., The global ...
Breaking Medicine News(10 mins):Health News:2014 Brown Evening Dresses Added To iFitDress.com 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3
... Nov. 6 Par,Pharmaceutical Companies, Inc. (NYSE: PRX ) ... Third Quarter and Nine Month Results, For the ... $149.0 million and net income of $1.7 million, or $0.05 ... million,and net income of $1.3 million, or $0.04 per diluted ...
... Atlanta, Ga. November 06, 2008 Down syndrome, ... in approximately 1-in-700 births in the United States. Additionally, ... lost before birth. , The Centers for Disease Control ... convened a meeting of experts to review the current ...
... ResMed Inc. (NYSE: RMD ),today announced record revenue ... Revenue for the quarter was $217.9 million, a 17%,increase ... current,quarter, income from operations was $36.6 million and net ... respectively, compared to the quarter,ended September 30, 2007. Diluted ...
... cosmetics or a workplace chemical are often to blame, ... A wide variety of substances can cause the skin ... effectively managed with proper diagnosis and treatment, experts say. ... of the skin resulting from contact with a chemical, ...
... MVP Health Care, a leading,regional not-for-profit health ... Vermont and New Hampshire, has selected IncentOne, the ... to MVP and,Preferred Care health plan members through ... Care health plans that utilize the "WellStyle Extras",option, ...
... chosen by their teachers from four counties, San,Bernardino, Riverside, ... BERNARDINO, Calif., Nov. 6 On Sunday, November 9,2008 ... philanthropic,arm of Stater Bros. Markets, in conjunction with KFRG ... to community children on the field,of the Arrowhead Credit ...
Cached Medicine News:Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 2Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 3Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 4Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 5Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 6Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 7Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 8Health News:Par Pharmaceutical Reports Third Quarter 2008 Results 9Health News:ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008 2Health News:ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008 3Health News:ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008 4Health News:ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008 5Health News:ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008 6Health News:ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008 7Health News:Dermatitis Can Have Many Causes 2Health News:MVP Health Care and IncentOne Partner to Provide Member Incentives for MVP and Preferred Care 'WellStyle Extras' Program 2Health News:Stater Bros. Charities, KFRG Radio Stations and Loma Linda University Children's Hospital Will Present More Than 1,100 Brand-New Bikes to 4th Grade Students! 2
... Saturated Swabsticks are packaged ... foil-laminated pouches. Each 4 ... with precisely the correct ... package is terminally sterilized, ...
... alcohol and 10% povidone iodine formulated ... a barrier on the skin. The ... the povidone iodine, giving persistent protection ... catheter related infections for up to ...
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
... Aplicare's saturated swabsticks are packaged in easy ... inch swabstick is saturated with precisely the ... Gel Swabstick is saturated with a multi-purpose ... gel is also approved for venipuncture site ...
Medicine Products: